Keryx Biopharmaceuticals, Inc. To Host Conference Call on Third Quarter 2010 ... - PR Newswire (press release) PDF Print
PR Newswire (press release)The Phase 3 clinical program of Zerenex in the treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is being

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.